Dr. Williams is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2770 Cortez Ave
Idaho Falls, ID 83404Phone+1 208-522-4000Fax+1 208-528-4254
Summary
- Dr. Todd Williams is a gastroenterologist in Idaho Falls, ID and is affiliated with multiple hospitals in the area to include Idaho Falls Community Hospital, Mountain View Hospital and Eastern Idaho Regional Medical Center. He received his medical degree from University of New Mexico School of Medicine and has been in practice 18 years. He specializes in advanced endoscopic interventional, gastrointestinal functional & motility disorders, and inflammatory bowel disease. He has more than 10 publications and over 500 citings.
Education & Training
- University of New Mexico School of MedicineFellowship, Gastroenterology, 2002 - 2005
- University of New Mexico School of MedicineResidency, Internal Medicine, 1999 - 2002
- University of New Mexico School of MedicineClass of 1999
Certifications & Licensure
- ID State Medical License 2005 - 2026
- NM State Medical License 1999 - 2008
- National Board of Physicians and Surgeons Gastroenterology
- National Board of Physicians and Surgeons Internal Medicine
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Publications & Presentations
PubMed
- 15 citationsAn unmet clinical need: The history of thrombus imagingGregory M. Lanza, Grace Cui, Anne H. Schmieder, Huiying Zhang, John S. Allen
Journal of Nuclear Cardiology. 2019-06-01 - 33 citationsLocal Intratracheal Delivery of Perfluorocarbon Nanoparticles to Lung Cancer Demonstrated with Magnetic Resonance Multimodal Imaging.Wu Lina, Xiaofei Wen, Xiance Wang, Chunan Wang, Xilin Sun
Theranostics. 2018-01-01 - 14 citationsDual-therapy with αvβ3-targeted Sn2 lipase-labile fumagillin-prodrug nanoparticles and zoledronic acid in the Vx2 rabbit tumor model.Alison K. Esser, Anne H. Schmieder, Michael H. Ross, Jingyu Xiang, Xinming Su
Nanomedicine. 2016-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: